Metastatic colorectal cancer: Prognostic and predictive factors

Research output: Contribution to journalReview articlepeer-review


Colorectal cancer represents the third most frequently occurring cancer worldwide. In the last decade, the survival of patients affected by metastatic colorectal cancer (mCRC) has improved through the introduction of biological drugs. However, in this new and dynamic therapeutic context, research about prognostic and predictive factors is important to guide the oncologists to effective therapies as well as to improve the understanding of colorectal cancer biology. Their identification is an intensive area of research and our future goal will be to depict tumour-specific "molecular signa-tures" in order to predict the clinical course of the disease and the best treatments. In this report, we describe clinical, pathological and molecular biomarkers that can play a role as prognostic or predictive factors in mCRC.

Original languageEnglish
Pages (from-to)2779-2791
Number of pages13
JournalCurrent Medicinal Chemistry
Issue number17
Publication statusPublished - Jan 1 2020


  • Biologic therapy
  • Chemotherapy
  • Colorectal cancer
  • Metastases
  • Predictive factors
  • Prognostic factors

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'Metastatic colorectal cancer: Prognostic and predictive factors'. Together they form a unique fingerprint.

Cite this